Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
Oncology·MeSH: Leukemia, Lymphocytic, Chronic, B-Cell
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| prt2527 | Prelude Therapeutics Inc (PRLD) |
Frequently asked questions
How many drugs are in development for Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)?
BioSniper tracks 1 drug in development for Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL) across 1 company.
How many clinical trials target Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)?
There are 1 clinical trial targeting Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL) tracked by BioSniper.
Deep-dive into Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis